Antimicrobial Resistance During COVID-19 Gained New Ground: Expert Perspective
Widespread antibiotic prescribing in the first year of the pandemic set back US progress on the fight against antimicrobial resistance, says Anne Meneghetti, MD.
Study Analyzing Efficacy of Nonhormonal Contraceptive Gel, Phexxi, for Prevention of Chlamydia, Gonorrhea Completes Last Subject Last Visit
Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 25, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Novel Rapid-acting Treatment for Major Depressive Disorder First to Get FDA Nod
The dextromethorphan HBr-bupropion HCI combination uses the first new oral MOA in 6 decades and is labeled to improve depressive symptoms starting at 1 week.
Diagnoses of Youth-onset Type 2 Diabetes Spiked by 77% During First Year of COVID-19
Youth newly diagnosed with T2D also were metabolically sicker, with higher HbA1c, serum glucose levels, and BMI at presentation.
Three Flu Season Imperatives: Vaccinate the Young, the Old, and Everyone in Between
Influenza season in the southern hemisphere is "substantial," says Dr William Schaffner. To prepare: "Vaccinate, vaccinate, vaccinate!"
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 24, 2022
Nonpharmacologic Treatments for Fibromyalgia: What Works for Which Symptoms?
Is acupuncture effective in reducing pain? Can exercise help patients with fibromyalgia sleep better? New systematic review and meta-analysis provides insight.
USPSTF Updated Guidance on Statin Use in Primary CVD Prevention Similar to 2016 Recommendations
The recommendations guide initiation of statin therapy in persons aged ≥40 years without a history of CVD and no current signs/symptoms of CVD.
COVID-19, Flu, or Both—There are Always Patients on the Fence
The patients on the vaccine fence are the ones that take the extra time and, over time, an added measure of patience for the clinician.
Moderna Requests Emergency Use Authorization for COVID-19 Bivalent Vaccine
Moderna filed with the FDA for emergency use authorization of a 50-µg dose of a BA.4./BA.5 Omicron-targeting bivalent booster vaccine for those aged ≥18 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 23, 2022
New Novo Nordisk Combination Rx Better than Components for T2D, Weight Loss
Phase II clinical trial shows a fixed dose combination of semaglutide/cagrilintide reduces HbA1c and weight much better than either drug alone.
Vegetarian Diet May Up Risk for Hip Fracture in Women
Among more than 26 000 women, a vegetarian diet was associated with a 33% greater risk of hip fracture vs diets that included fish or meat.
Seen in the ED: Diarrhea and BUQ Pain
The woman is in her mid-fifties, diarrhea has been persistent for 10 days and BUQ pain for 2 days. What does the CT show? What's your diagnosis?
US Vaccine Fatigue May Harbor Some Unrealistic Expectations
Vaccine fatigue in the US, says Vanderbilt University's William Schaffner, MD, is plentiful for vaccines that are are good—but not perfect.
Pfizer-BioNTech Request EUA for Bivalent COVID-19 Vaccine for Fall
Pfizer-BioNTech filed with the FDA for emergency use authorization of a 30-mcg dose of an Omicron BA.4.BA.5-adapted vaccine for those aged ≥12 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 22, 2022
HHS: Monkeypox Vaccine Production to Begin in the US as Cases Surpass 14 000
Federal officials have announced an agreement between Jynneos manufacturer Bavarian Nordic and a Michigan-based drug maker to "fill and finish" US-owned doses.
Don't Call them "Boosters" Anymore and Other COVID-19 Vaccine Recommendations
Let's call the next round of COVID-19 shots "updated vaccines," and help the public understand the true role of this vaccination, says NFID's Schaffner.